Endurant Capital Management LP Laboratory Corp Of America Holdings Transaction History

Endurant Capital Management LP

$0
Q1 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$197.69 - $227.29 $5.65 Million - $6.5 Million	-28,585 Reduced 87.77%	3,984 $905,000
Q2 2023 Aug 14, 2023	SELL	$211.93 - $241.33 $2.69 Million - $3.06 Million	-12,671 Reduced 28.01%	32,569 $7.86 Million
Q1 2023 May 15, 2023	SELL	$213.32 - $257.83 $9.75 Million - $11.8 Million	-45,684 Reduced 50.24%	45,240 $10.4 Million
Q4 2022 Feb 14, 2023	SELL	$203.72 - $248.97 $1.29 Million - $1.57 Million	-6,321 Reduced 6.5%	90,924 $21.4 Million
Q3 2022 Nov 14, 2022	BUY	$204.81 - $262.19 $12.8 Million - $16.4 Million	62,527 Added 180.1%	97,245 $19.9 Million
Q2 2022 Aug 15, 2022	SELL	$213.86 - $277.87 $5.68 Million - $7.38 Million	-26,561 Reduced 43.34%	34,718 $8.14 Million
Q1 2022 May 16, 2022	SELL	$259.82 - $298.18 $1.06 Million - $1.22 Million	-4,093 Reduced 6.26%	61,279 $16.2 Million
Q4 2021 Feb 14, 2022	BUY	$271.6 - $314.21 $12.6 Million - $14.6 Million	46,543 Added 247.19%	65,372 $20.5 Million
Q3 2021 Nov 15, 2021	SELL	$274.82 - $308.34 $12.1 Million - $13.6 Million	-44,090 Reduced 70.07%	18,829 $5.3 Million
Q2 2021 Aug 16, 2021	BUY	$251.87 - $278.14 $4.46 Million - $4.92 Million	17,695 Added 39.13%	62,919 $17.4 Million
Q1 2021 May 17, 2021	BUY	$204.88 - $255.03 $5.2 Million - $6.48 Million	25,390 Added 128.01%	45,224 $11.5 Million
Q4 2020 Feb 16, 2021	BUY	$186.91 - $214.42 $3.71 Million - $4.25 Million	19,834 New	19,834 $4.04 Million
Q3 2020 Nov 16, 2020	SELL	$167.03 - $201.3 $6.33 Million - $7.63 Million	-37,915 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$113.31 - $182.44 $1.31 Million - $2.11 Million	11,571 Added 43.92%	37,915 $6.3 Million
Q1 2020 May 15, 2020	SELL	$104.32 - $195.28 $8.52 Million - $16 Million	-81,699 Reduced 75.62%	26,344 $3.33 Million
Q4 2019 Feb 14, 2020	BUY	$163.48 - $173.61 $3.12 Million - $3.31 Million	19,060 Added 21.42%	108,043 $18.3 Million
Q3 2019 Nov 14, 2019	BUY	$159.77 - $178.1 $971,880 - $1.08 Million	6,083 Added 7.34%	88,983 $14.9 Million
Q2 2019 Aug 14, 2019	BUY	$144.16 - $172.9 $5.48 Million - $6.58 Million	38,031 Added 84.76%	82,900 $14.3 Million
Q1 2019 May 15, 2019	BUY	$123.7 - $156.3 $5.55 Million - $7.01 Million	44,869 New	44,869 $6.86 Million
Q3 2018 Nov 14, 2018	SELL	$167.67 - $188.27 $209,419 - $235,149	-1,249 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$160.33 - $189.41 $4.54 Million - $5.37 Million	-28,326 Reduced 95.78%	1,249 $224,000
Q1 2018 May 15, 2018	BUY	$161.53 - $178.11 $1.45 Million - $1.6 Million	9,000 Added 43.74%	29,575 $4.78 Million
Q4 2017 Feb 14, 2018	BUY	$147.99 - $163.95 $3.04 Million - $3.37 Million	20,575	20,575 $3.28 Million

Others Institutions Holding LH

# of Institutions

Shares Held

1.94M

Call Options Held

Put Options Held

View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

More about LH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.

Account